New-prescription Alert for Deep Vein Thrombosis
This trial will test whether getting alerts about high-risk prescriptions from pharmacists, instead of doctors, will lead to more changes in prescriptions.
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism
- Atrial Fibrillation
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment still available for this clinical trial?
"Yes, according to clinicaltrials.gov this healthcare trial is still enrolling participants. It was initially published on August 1st 2022 and the most recent update was made 3 days later. The research team intends to recruit 5000 people from one centre."
To what extent has participation been seen in this trial?
"Affirmative. Per the information on clinicaltrials.gov, this medical trial is actively recruiting participants. It was first made available to patients on August 1st 2022 and has been updated as recently as August 3rd of that same year. 5,000 individuals will be admitted across a single site location."